Behçet’s Disease
Reference48 articles.
1. Ahn, J. K., Lee, Y. S., Jeon, C. H., Koh, E. M., & Cha, H. S. (2008). Treatment of venous thrombosis associated with Behcet’s disease: Immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clinical Rheumatology, 27, 201–205. 2. Al-Araji, A., & Kidd, D. P. (2009). Neuro-Behcet’s disease: Epidemiology, clinical characteristics, and management. Lancet, 8, 192–204. 3. Alpagut, U., Ugurlucan, M., & Dayioglu, E. (2007). Major arterial involvement and review of Behcet’s disease. Annals of Vascular Surgery, 21, 232–239. 4. Arida, A., Fragiadaki, K., Giavri, E., & Sfikakis, P. P. (2011). Anti-TNF agents for Behçet’s disease: Analysis of published data on 369 patients. Seminars in Arthritis and Rheumatism, 41, 61–70. 5. Borhani Haghighi, A., Ittehadi, H., Nikseresht, A. R., Rahmati, J., Poorjahromi, S. G., & Pourabbas, B. (2009). CSF levels of cytokines in neuro-Behcet’s disease. Clinical Neurology and Neurosurgery, 111, 507–510.
|
|